PROMOGRAN™ Matrix Wound Dressing, PG019, Hexagon 123 cm2 (19.1 sq in), 10/Ct, 4 Cts/Cs
About the product
The Promogran Matrix Family of collagen dressings have been shown to be effective through multiple Randomized Controlled Trials (RCTs), that have been systematically reviewed in meta-analysis.(1)(2)
Product Details
The Promogran Matrix Family of collagen dressings have been shown to be effective through multiple Randomized Controlled Trials (RCTs), that have been systematically reviewed in meta-analysis.(1)(2)
Studies have shown that the Promogran Matrix Family of collagen dressings:
Are cost effective and have the potential to lower the cost of total treatment(3)
Can significantly increase the number of wounds closed(1)(2)
When used early in wound management, may lead to improved success rates(4-7)
3M™ Promogran™ Collagen Matrix with ORC is comprised of a sterile freeze-dried composite of 45% oxidized regenerated cellulose (ORC) and 55% collagen.
In the presence of exudate, Promogran Matrix transforms into a soft, confirmable, biodegradable gel, and thus allows contact with all areas of the wound. The dressing helps create a moist wound bed and an environment that supports wound healing.
During dressing changes it is not necessary to remove any residual dressing.
- Unlike any other collagen dressing.
- The 3M™ Promogran™ Matrix Family of collagen dressings are the most studied collagen dressings in the world.
- The Promogran Matrix Family are the only collagen dressings uniquely formulated with Oxidized Regenerated Cellulose (ORC).
Suggested Applications
- Promogran Matrix is intended for the management of exuding wounds including: Diabetic ulcers, Venous ulcers, Pressure ulcers, Ulcers caused by mixed vascular etiologies, Full-thickness & partial thickness wounds, Donor sites and other bleeding surface wounds, Abrasions, Traumatic wounds healing by secondary intention, and Dehisced surgical wounds.
- Promogran Matrix may be used under compression therapy with healthcare professional supervision.
Legal
1. Chowdhry S.A, et al. Use of oxidised regenerated cellulose/collagen dressings versus standard of care over multiple wound types: a systematic review and meta-analysis. Int Wound J. 2021. 2. Chen Y, Du P, Lv G. A meta-analysis examined the effect of oxidised regenerated cellulose/collagen dressing on the management of chronic skin wounds. Int Wound J. 2023;20(5):1544-1551. doi:10.1111/iwj.14009CHENET AL.1551 3. Snyder, R. et al. A Retrospective Study of Sequential Therapy with Advanced Wound Care Products versus Saline Gauze Dressings: Comparing Healing and Cost. Ostomy Wound Management. 2010; 56(11A):9–15. 4. Cullen B, et al. Early adoption of collagen/ORC therapies improves clinical outcome. Paper presented at: Wounds UK Harrogate, 2011. 5. Gottrup F, Cullen B, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson M. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Repair & Regeneration. 2013; 21:1-10. 6. Veves A, Sheehan P, Pham HT. A randomised controlled trial of Promogran (a collagen/ oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002; 137(7):822-827. 7. Vin, F., Teot, L. and Meaume, S. (2002) The healing properties of Promogran in venous leg ulcers. J Wound Care, 11, 335-341.Product Specifications
| Brand |
Brand
Promogran™ |
| Surface Area (Imperial) |
Surface Area (Imperial)
19.0600 |
| Surface Area (Metric) |
Surface Area (Metric)
123.0000 |